WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'2701 Infant (under 12 months) mortality rate: 412
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 522

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 53'719  53'259  52'797  52'351  51'931  48'453  42'123  34'475 
Births 911  917  922  927  931  1'009  1'129  1'245 
Surviving infants 867  872  877  881  884  947  1'043  1'126 
Pop. less than 5 years 4'373  4'406  4'434  4'440  4'416  4'856  5'318  5'292 
Pop. less than 15 years 13'177  13'267  13'367  13'461  13'539  14'894  15'868  14'170 
Female 15-49 years 15'681  15'579  15'463  15'348  15'240  13'880  10'704  8'133 

Number of reported case

(Click for retrospective incidence data for Myanmar)
Diphtheria 29  38  19  17  181  830 
Japanese encephalitis 50  14  20  18 
Measles 122  1'010  2'175  2'046  190  845  7'900  21'457 
Mumps
Pertussis 14  55  7'882  26'878 
Polio* 44  47  244 
Rubella 30  23  21  103  11 
Rubella (CRS)
Tetanus (neonatal) 32  39  29  32  19  41  27  124 
Tetanus (total)** 73  73  75  178  96  312  769  2'423 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Myanmar)
Vaccine year result method % card seen                                                
BCG 2008  98  MICS   96  92  86  87  93  93  88  67 
DTP1 2008  98  MICS   96  92  90  89  88  93  87 
DTP3 2008  98  MICS   96  88  75  84  86  90  82  69 
DTP4         
IPV1         
HepB_BD         
HepB3 2008  98  MICS   96  88  72  38  90 
Hib3          88  72 
JapEnc         
MCV1          88  86  84  88  88  84  68 
MCV2          82  80  80  75 
PCV1         
PCV3         
Pol3 2008  98  MICS   96  88  76  87  90  90  86  69 
Rota1         
Rota_last         
Rubella1         
TT2plus 1999  78  MICS   52  85  81  85  87  86  81  56 
PAB         
VAD1          95  95  95 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Myanmar)
BCG 86  86  87  93  93  88  95 
DTP1 90  90  89  88  93  87  96  22 
DTP3 75  75  84  84  90  82  88 
HepB3 75  75  58  40  92 
HepB_BD
Hib3 75  75 
MCV1 86  86  84  88  88  84  68 
MCV2 80  80  80  75 
PAB 87  87  93  93  93  79  62 
PCV3
Pol3 76  76  87  90  90  88  88 
Rota_last

Number of districts in the country 330  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
99 
   
/
|
|
\
Greater or equal to 90% 59
From 80 to 89% 24
From 50 to 79% 9
Less than 50% 5
Proportion of districts
not reporting DTP3 coverage
3
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6 months; Yes
Measles 9, 18 months; Yes
OPV 2, 4, 6 months; Yes
TT 1st contact pregnancy; +4 weeks; Yes
VitaminA 6-59, 13-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016    2012-2016  2007-2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 330  330  324  330  319  300  325 

System performance

Total Nº districts in country number 330  330  330  330  325  325  325 
Nº districts with DTP3 coverage >=80% number 273  147  214  252  284  289  225 
% of districts with DTP3 coverage >=80% From 0 to 100% 83  45  65  76  87  89  69 
Nº districts with measles (MCV1) coverage >=95% number 106  86  74  81  81  62  56 
% of districts with MCV1 coverage >=95% From 0 to 100% 32  26  22  25  25  19  17 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%     23         

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.